Objective: The effect of iron status in pregnant women on expression of ferritin receptor in placental microvilli membrane at mid-term gestation was investigated. Design: Ferritin receptor binding sites and dissociation constants (K d ) were determined in specimens of placental microvilli from 30 pregnant women at mid-term gestation and six women at term-delivery. Results: The ferritin receptor binding sites in the placental microvilli membrane in pregnant women with mild iron de®ciency and moderate iron de®ciency anemia were signi®cantly higher then those in pregnant women with normal iron status. However, no signi®cant difference was found between pregnant women with severe iron de®ciency anemia and with normal measurements. No signi®cant differences of K d values were detected between pregnant women with normal iron status and those with iron-de®ciency. Data also revealed that the ferritin receptor binding sites in placental microvilli membrane and K d values at mid-term gestation did not differ signi®cantly from those at term gestation. Conclusion: Lower iron status in pregnant women could lead to an increase in expression of ferritin receptor in placental microvilli membrane at mid-term gestation while the dissociation constant of ferritin receptor remains unchanged. This implies that the regulation of maternal ± fetal iron homeostasis via the ferritin receptor-mediated pathway is achieved by changes in the numbers of ferritin receptors rather then binding properties. Sponsorship: China Natural Science Foundation and The Hong Kong Polytechnic University. Descriptors: ferritin receptor; placental microvilli; iron status; pregnant women; maternal-fetal iron homeostasis
Introduction
Iron de®ciency anemia is the most prevalent nutritional problem in the world. During their reproductive years and particularly during pregnancy women are at high risk for iron de®ciency anemia. In developing countries, the prevalence of iron de®ciency anemia in pregnant women ranges from 35% to 75% (WHO, 1992) . The prevalence of pregnant women suffering from iron de®ciency with or without anemia is reported to be as high as 40 ± 90% . A number of studies have indicated that iron de®ciency anemia during pregnancy may be associated with an increased cases of prematurity and perinatal mortality (Lops et al, 1995; Allen, 2000; Rush, 2000; Yip, 2000) . However, how iron de®ciency in pregnant women affects the iron metabolism and iron status of their fetuses remains to be established. In this study, we investigated the effect of iron status of pregnant women on the expression of a ferritin receptor (FnR) in the placental microvilli membrane at mid-term gestation. The possible roles of placental FnR in iron transport across the placenta and the in¯uences of iron de®ciency in pregnant mothers on the iron status of their fetuses were discussed.
Methods

Grouping criteria
The procedures of this study received ethical approval from the research committee of West China University of Medical Sciences. All pregnant women participating in this study did so voluntarily. The purpose of the study was explained and informed consent was obtained. Thirty pregnant women at mid-term gestation were divided into four groups: G1, normal measurements; G2, mild iron de®ciency; G3, moderate iron de®ciency anemia; and G4, severe iron de®ciency anemia. The grouping criteria are summarized in Table 1 . Because multiple criteria are more sensitive and speci®c to de®ne iron de®ciency than any one single criterion (Rusia et al, 1999) , in this study multiple criteria were used. Women were considered to have iron de®ciency anemia when, besides a hemoglobin (Hb) value of 110 gal (moderate anemia) or 90 gal (severe anemia), they also ful®lled two or more of the following independent indicators: serum iron 10.7 mmolal, total iron binding capacity (TIBC) ! 62.7 mmolal, and transferrin saturation (TS) 0.15, as well as decreased serum ferritin (SF) 20 mgal andaor decreased erythrocyte ferritin (EF) 6.5 agaRBC (see Table 1 ). The SF level of 20 mgal was used as the cut-off point for iron de®ciency in this study according to CAPH (Chinese Association of Pediatric Hematology) criteria (Liao et al, 1992; Lin, 1995 ). This cut-off level was achieved based on a large-scale investigation of the relationship between SF and stainable bone marrow iron. Specimens of the placentas of 30 pregnant women at mid-term gestation were collected with therapeutic abortion. Before abortion, maternal peripheral blood samples were obtained via venipuncture for the measurements of Hb, serum iron, TIBC, TS, SF and EF. In addition, the specimens of placenta were collected at term delivery from six different pregnant women with normal measurements of iron indicators, as described in G1 for the determination of FnR expression.
Assessment of iron status
Serum iron and TIBC were determined by using commercial kits (Sigma, St Louis, MO, USA; Qian et al, 1999) . TS was calculated by the formula: TS SIaTIBC (%). SF was quantitated by ELISA, using kits from RAMCO Laboratories, Houston, TX, USA. EF was determined by the method described by Ohhara (1993) with some modi®ca-tion. Brie¯y, heparin anticoagulated blood was diluted with two volumes of normal saline and then passed through degreasing cotton column to remove white blood cells. Red blood cells were washed twice with heparinized normal saline and them centrifuged for 10 min. The supernatant was discarded and the precipitated red cell pellet was diluted with normal saline to a cell concentration of 2 ± 4Â10 12 al. After thawing (À20 C) three times and being centrifuged for 10 min, the supernatant was collected for the measurement of ferritin concentration by using the same assay for the determination of serum ferritin. EF was calculated by the formula: EF measured value (mgal)aRBC concentration.
Preparation of membrane
Protein of placental microvilli membrane was prepared according to the procedures of Smith et al (1974 Smith et al ( , 1977 and Smith and Brush (1978) with some modi®cation (Liao et al, 1992; Luo et al, 1996) . In brief, portions of placenta (about 50 g) were rinsed rapidly in ice-cold Kreb's physiological saline to remove much of the blood. The tissue was gently spread out manually and stirred in 500 ml ice-cold 0.9% NaCl so that the chorionic villi¯oated out and were well irrigated by the saline. After 30 min gentle agitation at 0 C using a magnetic stirrer, the saline wash was decanted and centrifuged, ®rst at 800 g for 10 min to remove tissue fragments and red blood cells, and then at 10 000 g for 1 min to remove miscellaneous particles. Finally, the still cloudy supernatant was centrifuged at 50 000 g for 1 h, when a clear jelly-like pellet was obtained. Electron microscopy of this pellet revealed that it was a homogeneous collection of membrane vesicles. Enzyme membrane markers, alkaline phosphatase (3.1.6.1) and 5 H -nucleotidase (3.1.3.5), were measured by a modi®cation of the method of Sterling et al (1964) and by the method of Michell and Hawthorne (1965) respectively, and found to be considerably enriched in the microvillous preparation. The preparation is indeed a syncytiotrophoblast plasma membrane.
Determination of ferritin receptor binding sites
The 125 I-apoferritin was prepared by the one-step linkage labeling with horse spleen apoferrin, 125 I-Na, and Bolton- Multiple criteria are more sensitive and speci®c in de®ning iron de®ciency than any one single criterion and therefore are used in this study. Women were considered to have iron de®ciency anemia when, besides a hemoglobin (Hb) value of 110 gal (moderate anemia) or 90 gal (severe anemia), they also ful®lled any two or more of independent indicators (serum iron, TIBC and TS), as well as decreased SF andaor decreased EF. The SF level of 20 mgal was used as the cut-off point for iron de®ciency according to CAPH criteria (refer to`Methods' section for details). a ID, Iron de®ciency; b IDA, iron de®ciency anemia.
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Hunter-reagent (Sigma) (Luo et al, 1996) . The binding of 125 I-apoferritin with placental microvilli membrane was analyzed by radioligand assay as previously described (Liao et al, 1992; Luo et al, 1996) . In brief, placental microvilli protein (160 mg) and 125 I-apoferritin (80 ng) were added to test tubes numbered from 1 to 10. Unlabeled apoferritin 0.5 ± 80 mg was added to test tubes of nos 2 ± 9, and test tube no. 10 was designated as a nonspeci®c binding tube to which 120 mg of apoferritin was added. The total reaction volume in all of test tubes was adjusted to 0.5 ml using isotonic 0.01 M Tris ± HCl solution (pH 7.4) containing 0.1% bovine serum albumin (BSA). After total radioactivity (T) was detected by a Geiger counter, each test tube was incubated in 37 C for 30 min in a shaking water bath and underwent a regular shaking every 5 min. Reactions were terminated in an ice incubator, and then 0.1 ml isotonic 0.01 M Tris ± HCl (pH 7.4) containing 0.084% gglobulin and 0.6 ml of 12% PEG were added into each tube. After having been mixed completely and then left undisturbed at 4
C for 1 h all of the tubes were centrifuged for 30 min (3500 rpm) and the supernatant was discarded. Then the precipitant radioactivity (B) was detected. The speci®c BaT was calculated. The inhibition curve was plotted with the unlabeled apoferritin concentration as transverse axis and the speci®c BaT as longitudinal axis. Finally, the FnR binding sites per milligram of placental microvilli protein and the dissociation constant (K d ) of FnR were calculated by the Scatchard plotting method, employing the DP.EXE software.
Results
Characteristics and indicators of iron status of study samples
The pregnant women ranged in age from 21 to 36 y, with an average of 27 AE 10.9 y. None of women smoked cigarettes, and alcohol consumption was rare. The gestational ages of G1 (normal group), G2 (mild iron de®ciency), G3 (moderate iron de®ciency anemia) and G4 (severe iron de®ciency anemia) were 20.7 AE 3.9, 21.6 AE 3.9, 21.2 AE 3.7 and 20.2 AE 2.6 weeks, respectively ( Table 2 ). The weight of the pregnant women was measured to the nearest 0.1 kg with a battery-powered digital scale (Chengdo, SC, PRC), being 49.3 AE 4.0, 48.0 AE 4.7, 48.2 AE 2.9, and 46.8 AE 3.0 in G1, G2, G3 and G4, respectively. Height was determined to the nearest 0.1 cm with a stationary height board fastened to the wall, being 1.67 AE 0.06, 1.57 AE 0.06, 1.60 AE 0.04 and 1.56 AE 0.04 in G1, G2, G3 and G4, respectively. Parity of all women in this study was 1. The measurements of indicators of iron status of study samples in different groups, including Hb, serum iron, TIBC, TS, SF and EF are listed in Table 2 .
Iron status in pregnant women and ferritin receptor expression in placental microvilli membrane at mid-term gestation
The specimens of placenta of pregnant women at mid-term gestation were collected with therapeutic abortion. Placental microvilli membrane was prepared and FnR binding sits were determined. The results showed that FnR binding sites in G1, G2, G3 and G4 are 9.63 AE 4.72, 15.28 AE 8.36, 14.44 AE 6.13 and 9.37 AE 6.37, respectively. The pregnant women in G2 and G3 have a signi®cant higher number of FnR binding sites than those in G1 (both P`0.05). This implies that mild iron de®ciency and moderate iron de®-ciency anemia can lead to an increase in the expression of FnR in placental microvilli membranes in pregnant women at mid-gestation. No signi®cant difference was found between the FnR binding sites of G1 and G4 (P b 0.25). This result suggests that severe iron de®ciency anemia in pregnant women at mid-gestation has no such effect on FnR expression. The dissociation constants (K d ) were 9.47 AE 5.27, 10.36 AE 3.76, 9.22 AE 1.45 and 8.57 AE 4.20 in Weight was measured to the nearest 0.1 kg with a battery-powered digital scale and height was determined to the nearest 0.1 cm with a stationary height board fastened to the wall. The parity of all women in this study was 1. Maternal peripheral blood samples were obtained before abortion for the measurements of Hb, serum iron, TIBC, TS, SF and EF. The results are meansAE s.d.
a Group 1, Normal iron status; group 2, mild iron de®ciency; group 3, moderate iron de®ciency anemia; Group 4, severe iron de®ciency anemia.
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G1, G2, G3 and G4, respectively. No signi®cant difference was detected between normal pregnant women and those with iron de®ciency or iron de®ciency anemia (Table 3) .
Ferritin receptor expression and dissociation constant (K d ) in placental microvilli membrane at mid-term and at term gestation
To determine the effect of gestation time on expression of FnR, the six specimens of placenta were also collected from six pregnant women at term delivery with normal measurements of iron indicators as described in G1, and the FR binding sites and dissociation constants (K d ) were investigated. The FnR binding site in term pregnancy with normal iron measurements was 9.87 AE 4.72 and dissociation constant (K d ) was 7.99 AE 3.23 respectively (Table  3) . No signi®cant difference was found compared to the corresponding values in mid-term pregnancy with normal iron status (both P b 0.25). The results revealed that the gestation time has no signi®cant effect on the expression of FnR and dissociation constant values in placental microvilli membrane in pregnant women (Table 3 ). There were no signi®cant interactions between term pregnancy and midterm pregnancy for any variables.
Discussion
The placenta is of pivotal importance for the intrauterine development of a fetus and is the essential organ of substance transportation to the fetus. Well-developed placental microvilli and intact placental blood circulation are prerequisites for adequate substance transfer across the placenta. Previous studies including ours (Loh et al, 1980; Tawada et al, 1985; Takami et al, 1986; Contractor & Eaton, 1986; Liao et al, 1992; Allen, 2000) have con®rmed that placental microvilli membrane abounds in transferrin receptor (TfR), an important iron transport protein. This protein plays a key role in iron transport from the maternal to the fetal circulation Contractor & Eaton, 1986; Liao et al, 1992; Allen, 2000) . TfR has two binding sites for diferric transferring (Tf). Tf-TfR complex enters the cell via endocytosis (Qian & Tang, 1995; Qian et al, 1997) . In endosome, iron is released from Tf and enters cytosol to take part in important biochemical processes such as Hb biosynthesis. The TfR then returns to cell membrane for re-utilization and reuptake of Tf-bound iron (Tf-Fe). In placenta, serum Tf carries iron from the maternal circulation to TfR located on the apical surface of the placental syncytiotrophoblast, holoTf is endocytosed, iron is released, and apoTf is returned to the maternal circulation. The free iron then binds to ferritin in placental cells where it is transferred to apoTf, which enters from the fetal side of the placenta and exits as holoTf into the fetal circulation (Allen, 2000) . Extensive studies indicate that an increase in the expression of TfR in placental microvilli might be a result of a compensatory mechanism with regard to iron de®ciency and mild iron-de®ciency anemia in pregnant mothers (Huebers, 1990) . However, the function of this compensatory system is believed to be limited based on the fact that the Tf saturation is remarkably decreased and the TfR expression is also hindered in pregnant women with severe iron de®ciency (Singla et al, 1996; Allen, 2000) . In addition, it was reported that iron status in fetuses whose mothers were suffering from iron de®ciency is normal or nearly normal, being independent of maternal iron status (Gebre-Medhin & Birgegard, 1981; Dallman, 1989; Bhargava et al, 1991; Lao et al, 1991; Institute of Medicine, food and Nutrition Board, 1993; Hokama et al, 1996) , although different results have been reported (Blot et al, 1999) . These ®ndings imply that there might be some other mechanisms involved in the regulation of maternal-fetal iron transport. Previous studies have demonstrated that FnR, in addition to TfR, is present on the membranes of many normal cells (Moss et al, 1992) , including reticulocytes (Blight and Morgan, 1987a) , lymphoblasts (Adams et al, 1992) , liver (Moss et al, 1988 ) and brain cells (Adams et al, 1992; Ramm et al, 1994; Hulet et al 1999) . This protein is also found to play a role in iron transport across the membrane of these cells (Blight and Morgan, 1987b; Moss et al, 1988; Osterloh & Aisen, 1989; Gelvan et al, 1996) and ferritin uptake by human erythroid precursors is a regulated iron The results are meansAE s.d. a G1, normal iron status; G2, mild iron de®ciency; G3, moderate iron de®ciency anemia; G4, severe iron de®ciency anemia; term pregnancy, specimens of placenta were collected from pregnant women at term delivery with normal measurements of iron indicators as described in G1. *P`0.05 vs group 1.
Expression of ferritin receptor QK Liao et al uptake pathway (Gelvan et al, 1996) . On the human placental microvillous membrane, the present of FnR has been well documented (Celada et al, 1980; Tawada et al, 1985; Takami et al, 1986; Contractor & Eaton, 1986; van Dijk, 1988) . A study of indirect immuno¯uorescence (Brown et al, 1979) shows that ferritin in placenta microvilli plays an important role in the transportation of maternal iron across the placenta. Tawada et al (1985) reported that iron is transferred from the mother to the fetus by the placental active function, and both TfR and FnR on trophoblasts participate in the adequate placental iron transport. Takami et al (1986) presumed that placental FnR could be another regulatory pathway of maternal ± fetal iron transfer based on their study. Okuyama et al (1985) demonstrated that FnR is present in every level of the trophoblast and suggested that FnR might act as a safety valve, regulating the transferred iron between mother and fetus and assuring a constant iron supply. An animal study in pregnant guinea pigs also revealed that ferritin-bound iron could be taken up by the placenta (Lamparelli et al, 1989) . Aisen (1991) pointed out that the placental FnR mediated-iron transfer pathway might be an alternative or a compensatory mechanism for cell iron supply when the TfR-mediated pathway was inadequate. Based on the above studies and the results of the present study, it might be reasonable to propose that FnR-mediated iron uptake by placental trophoblasts constitutes an iron transport pathway in addition to the classical TfR-mediated uptake pathway. It is highly likely that both might be the regulated iron uptake pathways in the placenta and could act coordinately to maintain adequate iron transport across the placenta. In pregnant women with normal iron status, maternal iron would be transferred to placental microvilli syncytial cells in the form of diferric Tf-TfR complex and ferritin-FnR complex. In such a case, the expression of both TfR and FnR is normal. In pregnant women with mild iron de®ciency and moderate iron de®ciency anemia, iron transport across the placenta via the TfR pathway might be adversely affected due to the unavailability of Tf-Fe with low Tf saturation. Therefore, expression of placental FnR and FnR-mediated iron uptake would increase, as revealed by our present study. The compensatory increase in FRmediated iron transport would be able to keep a constant iron supply from mother to fetus, although pregnant women with mild iron de®ciency and moderate iron de®ciency anemia have`inadequate' iron. It is probably the reason why iron status in fetuses whose mother is suffering from iron de®ciency is normal or nearly normal, as reported by some research groups (Gebre-Medhin & Birgegard, 1981; Dallman, 1989; Bhargava et al, 1991; Lao et al, 1991; Institute of Medicine, Food and Nutrition Board, 1993; Hokama et al, 1996) . Our results also show that there is no signi®cant difference in FnRs between pregnant women with severe iron de®ciency anemia and with normal measurements. The cause is unclear. However, it is possibly associated with severe iron de®ciency itself. It has been reported (Finch et al, 1983 ) that low levels of plasma iron, as found in severe iron de®ciency, could result in damage to fetal tissues and reduced capacity of placental tissues to take up iron. Singla et al (1996) demonstrated that a mild degree of maternal anemia has little in¯uence on iron accretion in the fetus. However, with increasing severity of maternal anemia, the fetus accumulates less and less iron, and levels of serum iron, Tf saturation and ferritin in the cord blood of severely anemic women is markedly decreased. It is likely that severe iron de®ciency anemia itself, in addition to being able to reduce TfR expression in pregnant women (Singla et al, 1996; Allen, 2000) , could damage the placenta and thus inhibit FnR expression. Further investigations are needed.
The results also revealed that the dissociation constant of FnR in placental microvilli membrane at mid-term gestation remained unchanged regardless of maternal iron status. This indicates that the regulation of maternal ± fetal iron homeostatis via the FnR-mediated pathway was achieved by changes in the numbers of FnR rather than binding ability. In addition, our result showed that, in pregnant women with normal iron status, ferritin binding sites and K d values in placental microvilli membrane at mid-term gestation did not differ signi®cantly from those at term gestation. It indicates that FnRs in placental microvilli play a very important role in the regulation of iron transport across the placenta, starting at least from the mid-stage of pregnancy. Adequate iron transport across the placenta might be maintained by the coordinate actions of the well-developed TfR-mediated pathway as well as the FnR-mediated pathway under normal conditions.
